DK161185D0 - Perhydrothiazepinderivater og fremgangsmaade til fremstilling deraf - Google Patents
Perhydrothiazepinderivater og fremgangsmaade til fremstilling derafInfo
- Publication number
- DK161185D0 DK161185D0 DK161185A DK161185A DK161185D0 DK 161185 D0 DK161185 D0 DK 161185D0 DK 161185 A DK161185 A DK 161185A DK 161185 A DK161185 A DK 161185A DK 161185 D0 DK161185 D0 DK 161185D0
- Authority
- DK
- Denmark
- Prior art keywords
- sup
- group
- heterocyclic
- aryl
- procedures
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/06—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/18—Radicals substituted by singly bound hetero atoms other than halogen by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polyesters Or Polycarbonates (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59071353A JPS60215678A (ja) | 1984-04-10 | 1984-04-10 | 6−アミノ−4−アザ−5−オキソ−1−チアシクロヘプタン誘導体 |
JP7135384 | 1984-04-10 | ||
JP27345184 | 1984-12-26 | ||
JP27345184 | 1984-12-26 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK161185D0 true DK161185D0 (da) | 1985-04-10 |
DK161185A DK161185A (da) | 1985-10-11 |
DK173297B1 DK173297B1 (da) | 2000-06-19 |
Family
ID=26412460
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK198501611A DK173297B1 (da) | 1984-04-10 | 1985-04-10 | Perhydrothiazepinderivater, fremgangsmåde til fremstilling deraf samt farmaceutisk præparat til behandling af hypertension |
DK199700643A DK173255B1 (da) | 1984-04-10 | 1997-06-02 | Perhydrothiazepinderivater og fremgangsmåde til fremstilling deraf samt farmaceutisk præparat til behandling af hypertensio |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK199700643A DK173255B1 (da) | 1984-04-10 | 1997-06-02 | Perhydrothiazepinderivater og fremgangsmåde til fremstilling deraf samt farmaceutisk præparat til behandling af hypertensio |
Country Status (15)
Country | Link |
---|---|
US (1) | US4699905A (da) |
EP (2) | EP0365045B1 (da) |
KR (1) | KR900002674B1 (da) |
AT (2) | ATE58146T1 (da) |
AU (1) | AU574455B2 (da) |
CA (1) | CA1266047A (da) |
DE (3) | DE3587674T2 (da) |
DK (2) | DK173297B1 (da) |
ES (2) | ES8702388A1 (da) |
FI (1) | FI87211C (da) |
HU (1) | HU193108B (da) |
IE (1) | IE63903B1 (da) |
NZ (1) | NZ211718A (da) |
RU (1) | RU1801110C (da) |
SU (1) | SU1435151A3 (da) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4512988A (en) * | 1984-03-01 | 1985-04-23 | E. R. Squibb & Sons, Inc. | Acylamino oxo or hydroxy substituted alkylamino thiazines and thiazepines |
JPH0637473B2 (ja) * | 1985-10-11 | 1994-05-18 | 三共株式会社 | ラクタム化合物 |
US4778790A (en) * | 1986-04-04 | 1988-10-18 | Sankyo Company Limited | Perhydrothiazepine and perhydroazepine derivatives and their therapeutic use |
US5041435A (en) * | 1988-08-13 | 1991-08-20 | Santen Pharmaceutical Co., Ltd. | Cyclic sulfur-containing compounds |
IL94295A0 (en) * | 1989-05-25 | 1991-03-10 | Fujisawa Pharmaceutical Co | Thiazepine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
US5552397A (en) * | 1992-05-18 | 1996-09-03 | E. R. Squibb & Sons, Inc. | Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase |
RU2124503C1 (ru) | 1992-05-18 | 1999-01-10 | И.Р.Сквибб энд Санз, Инк. | Гетероциклические азотсодержащие производные карбоновой кислоты, способ их получения и фармацевтическая композиция |
US5654294A (en) * | 1993-05-13 | 1997-08-05 | Bristol-Myers Squibb | Spiro lactam dual action inhibitors |
US5587375A (en) * | 1995-02-17 | 1996-12-24 | Bristol-Myers Squibb Company | Azepinone compounds useful in the inhibition of ACE and NEP |
US5877313A (en) * | 1995-05-17 | 1999-03-02 | Bristol-Myers Squibb | Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP |
US5650408A (en) * | 1995-06-07 | 1997-07-22 | Karanewsky; Donald S. | Thiazolo benzazepine containing dual action inhibitors |
US5635504A (en) * | 1995-06-07 | 1997-06-03 | Bristol-Myers Squibb Co. | Diazepine containing dual action inhibitors |
US7015212B1 (en) | 1999-05-12 | 2006-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Thiazepine inhibitors of HIV-1 integrase |
RS20050106A (en) | 2002-08-19 | 2007-11-15 | Pfizer Products Inc., | Combination therapy for hyperproliferative diseases |
CL2004000366A1 (es) * | 2003-02-26 | 2005-01-07 | Pharmacia Corp Sa Organizada B | USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA. |
SG141430A1 (en) | 2003-05-30 | 2008-04-28 | Ranbaxy Lab Ltd | Substituted pyrrole derivatives and their use as hmg-co inhibitors |
DE602006021600D1 (de) * | 2005-09-29 | 2011-06-09 | Fibrogen Inc | Verfahren zur senkung des blutdrucks |
US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
BRPI0618379A2 (pt) | 2005-11-08 | 2011-08-30 | Ranbaxy Lab Ltd | processo para preparação do hemi-sal de cálcio do ácido (3r,5r) -7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroxime tilfenilamino) carbonil]-pirrol-1-il] -3, 5-diidroxi heptanóico |
US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
CN100484936C (zh) * | 2006-02-27 | 2009-05-06 | 上海奥博生物医药技术有限公司 | (2s,6r)-6-氨基-2-(2-噻吩基)-1,4-硫氮杂卓-5-酮的合成方法 |
ATE547394T1 (de) | 2006-12-01 | 2012-03-15 | Bristol Myers Squibb Co | N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen |
KR101233139B1 (ko) * | 2011-04-21 | 2013-02-21 | 주식회사 한서켐 | 라세믹 1,4-티아제핀 화합물의 분할 방법 |
AU2014255381A1 (en) | 2013-04-17 | 2015-10-08 | Pfizer Inc. | N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases |
WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
JOP20210193A1 (ar) | 2019-01-18 | 2023-01-30 | Astrazeneca Ab | مثبطات pcsk9 وطرق استخدامها |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4287203A (en) * | 1980-04-23 | 1981-09-01 | Usv Pharmaceutical Corporation | Antihypertensive 1,4-thiazepine-ones, 1,4-thiazonine-ones, and method of use thereof |
IL63540A0 (en) * | 1980-08-18 | 1981-11-30 | Merck & Co Inc | Substituted enantholactam derivatives as antihypertensives |
US4587050A (en) * | 1980-08-18 | 1986-05-06 | Merck & Co., Inc. | Substituted enantholactam derivatives as antihypertensives |
EP0068173B1 (en) * | 1981-06-05 | 1984-09-26 | Merck & Co. Inc. | Perhydro-1,4-thiazepin-5-one and perhydro-1,4-thiazocin-5-one derivatives, process for preparing and pharmceutical composition containing the same |
US4460579A (en) * | 1983-02-28 | 1984-07-17 | E. R. Squibb & Sons, Inc. | Thiazine and thiazepine containing compounds |
US4512988A (en) * | 1984-03-01 | 1985-04-23 | E. R. Squibb & Sons, Inc. | Acylamino oxo or hydroxy substituted alkylamino thiazines and thiazepines |
-
1985
- 1985-04-09 US US06/721,303 patent/US4699905A/en not_active Expired - Lifetime
- 1985-04-09 SU SU853886502A patent/SU1435151A3/ru active
- 1985-04-10 AT AT85302524T patent/ATE58146T1/de active
- 1985-04-10 AU AU41058/85A patent/AU574455B2/en not_active Expired
- 1985-04-10 CA CA000478742A patent/CA1266047A/en not_active Expired - Lifetime
- 1985-04-10 DE DE3587674T patent/DE3587674T2/de not_active Expired - Lifetime
- 1985-04-10 IE IE89385A patent/IE63903B1/en not_active IP Right Cessation
- 1985-04-10 DE DE8585302524T patent/DE3580391D1/de not_active Expired - Lifetime
- 1985-04-10 DK DK198501611A patent/DK173297B1/da not_active IP Right Cessation
- 1985-04-10 KR KR1019850002440A patent/KR900002674B1/ko not_active IP Right Cessation
- 1985-04-10 EP EP89121428A patent/EP0365045B1/en not_active Expired - Lifetime
- 1985-04-10 HU HU851322A patent/HU193108B/hu unknown
- 1985-04-10 FI FI851433A patent/FI87211C/fi not_active IP Right Cessation
- 1985-04-10 NZ NZ211718A patent/NZ211718A/en unknown
- 1985-04-10 DE DE1999175024 patent/DE19975024I2/de active Active
- 1985-04-10 ES ES542127A patent/ES8702388A1/es not_active Expired
- 1985-04-10 AT AT89121428T patent/ATE97914T1/de not_active IP Right Cessation
- 1985-04-10 EP EP85302524A patent/EP0161801B1/en not_active Expired - Lifetime
-
1986
- 1986-08-21 ES ES557034A patent/ES8801229A1/es not_active Expired
- 1986-12-03 RU SU864028584A patent/RU1801110C/ru active
-
1997
- 1997-06-02 DK DK199700643A patent/DK173255B1/da not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK161185D0 (da) | Perhydrothiazepinderivater og fremgangsmaade til fremstilling deraf | |
NO164980C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemderivater. | |
FI941537A0 (fi) | Uudet tehokkaat, terminaalisen erilaistumisen indusoivat aineet sekä menetelmät niiden käyttämiseksi | |
ATE38675T1 (de) | Phosphatesterderivate und ihre verwendung als anti-krebsmittel. | |
AR247737A1 (es) | Un procedimiento para la fabricacion de compuestos. | |
IL66384A (en) | Indolin-2-one(3,4-dihydroquinol-2-one or quinol-2-one)-oxyalkylsulphimines and salts thereof,their preparation and pharmaceutical compositions containing them | |
FI821504A0 (fi) | Aminocyklopentanolsyror och -estrar och deras framstaellning och farmaceutiska komposition | |
DE3572815D1 (de) | 1,3-dithiole derivatives | |
ATE80886T1 (de) | Penemderivate. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B1 | Patent granted (law 1993) | ||
PUP | Patent expired |